Eam Investors, LLC Arvinas, Inc. Transaction History

Eam Investors, LLC

  • $616 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$65.85 - $96.21 $1.13 Million - $1.65 Million
-17,145 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$73.2 - $107.87 $1.26 Million - $1.85 Million
17,145 New
17,145 $1.41 Million
Q1 2021

May 11, 2021
SELL
$58.19 - $91.37 $1.54 Million - $2.42 Million
-26,534 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$20.19 - $84.93 $535,721 - $2.25 Million
26,534 New
26,534 $2.25 Million

Others Institutions Holding ARVN

# of Institutions
224
Shares Held
70.9M
Call Options Held
1.52M
Put Options Held
346K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $986M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email